Paving the Way for Breakthroughs in Oral Cancer Research
In the relentless pursuit of advancing our understanding and treatment of Oral cancer, Oracle Cancer Trust played a pivotal role in funding a groundbreaking research project led by Leah Ambler, a PhD student, that has contributed to two major publications that promise to reshape our approach to identifying metastatic cells in human oral cancer tissue.
The first of these groundbreaking research outputs is a paper published in eLife titled “Identification of Metastatic Cells in Human Oral Cancer Tissue.” The study delves deep into the intricate mechanisms underlying the metastasis of oral cancer cells, shedding light on the factors that contribute to the spread of this aggressive disease.
Link to the paper: Identification of Metastatic Cells in Human Oral Cancer Tissue
In addition to the academic publication, the research received recognition in the form of a digest from the journal, available here: eLife Digest. The digest provides a concise overview of the research, making it accessible to a broader audience and emphasizing its significance in the field of cancer research.
The second is a pre-print publication presenting a cutting-edge approach. The research utilizes a microfluidic model of metastasis to unravel the intricate interactions between cancer stem cells and the vasculature in oral cancer. This pre-print represents a leap forward in understanding the complexities of oral cancer metastasis, laying the groundwork for future advancements in therapeutic strategies.
Link to the pre-print: Microfluidic Model of Metastasis in Oral Cancer
In addition to contributing to these studies, Leah has built on these approaches and used our new understanding of the metastatic mechanisms of oral cancer to develop a prognostic signature for oral cancer spread. This is now being trialled in a larger retrospective group of patients which, if initial promising results are confirmed, could pave the way for a clinical test to tailor surgical decision making for oral cancer patients.
Oracle Cancer Trust’s commitment to advancing Head and Neck cancer research is exemplified through the recent successes in Leah’s groundbreaking studies and marks a step forward in the RACE to overcome the Head and Neck cancer crisis.
Follow us
Quick Links
Get in touch
Call 020 3875 8991
Email info@oraclecancertrust.org
Oracle Cancer Trust is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.